Danielle Holland
General Counsel bei AVEO PHARMACEUTICALS, INC.
Ursprung des Netzwerks ersten Grades von Danielle Holland
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 12 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Danielle Holland
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
ImClone LLC
 ImClone LLC BiotechnologyHealth Technology ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ. | Biotechnology | Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | General Counsel | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Veranova LP | Corporate Officer/Principal | ||
| EISAI CO., LTD. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Chief Operating Officer | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Undergraduate Degree | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Assumption College | College/University | Undergraduate Degree | |
| Brandeis University | College/University | Doctorate Degree | |
| Clark Atlanta University | College/University | Undergraduate Degree | |
| Florida State University | College/University | Undergraduate Degree | |
| Temple University (Pennsylvania) | College/University | Undergraduate Degree | |
| University of Massachusetts | College/University | Graduate Degree | |
| Worcester Polytechnic Institute | College/University | Undergraduate Degree | |
| St. Lawrence University | College/University | Undergraduate Degree | |
| ARGENX SE | Pharmaceuticals: Other | Corporate Officer/Principal | |
| IMV INC. | Biotechnology | Chairman | |
Hogan Lovells US LLP
 Hogan Lovells US LLP Miscellaneous Commercial ServicesCommercial Services Hogan Lovells US LLP provides legal services. The firm’s clients include corporations, financial institutions, and governments. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| VERASTEM, INC. | Biotechnology | Corporate Officer/Principal | |
| Harvard Law School | College/University | Graduate Degree | |
| Mendoza College of Business | College/University | Masters Business Admin | |
| HORIZON DISCOVERY GROUP PLC | Medical Specialties | Chief Operating Officer | |
| University of San Francisco School of Management | College/University | Masters Business Admin | |
Enzyvant, Inc.
 Enzyvant, Inc. Pharmaceuticals: MajorHealth Technology Part of Sumitomo Chemical Co., Ltd., Enzyvant, Inc. develops biopharmaceutical products. The company is based in Cambridge, MA. William T. Symonds has been the CEO of the company since 2022. | Pharmaceuticals: Major | Chief Operating Officer | |
Enzyvant Therapeutics, Inc.
 Enzyvant Therapeutics, Inc. BiotechnologyHealth Technology Enzyvant Therapeutics, Inc. develops biopharmaceutical products. It focuses on developing transformative therapies for rare diseases with high unmet needs. The company is headquartered in Cambridge, MA. | Biotechnology | Chief Operating Officer |
Statistik
International
| Vereinigte Staaten | 30 |
| Japan | 2 |
| Niederlande | 2 |
| Kanada | 2 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 21 |
| Consumer Services | 13 |
| Commercial Services | 2 |
Operativ
| Corporate Officer/Principal | 16 |
| Undergraduate Degree | 7 |
| Chief Operating Officer | 7 |
| Director/Board Member | 4 |
| Sales & Marketing | 3 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Danielle Holland
- Unternehmensverbindungen
